Systemic immune-inflammation index is associated with clinical outcome of acute ischemic stroke patients after intravenous thrombolysis treatment
PLOS ONE · 27.03.2025 · 20 (3) · e0319920
DOI: 10.1371/journal.pone.0319920 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 27.03.2025. Verfasst von Yuanfeng Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu Medical College, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Thrombolytic Therapy, Inflammation, Brain Ischemia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, the Medical Research and Youth Innovation Project of Sichuan Province, the Educational Reform Project of Chengdu Medical College.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
The systemic immune-inflammation index (SII) has been proven to predict the outcome in cancerous and non-cancerous diseases. We aimed to investigate the relationship between SII and other inflammatory markers and the prognosis in patients receiving intravenous thrombolysis (IVT).
Methods
Acute ischemic stroke patients treated with IVT were collected retrospectively. SII, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were constructed based on admission blood testing. Favorable outcome was defined as modified Rankin Scale of less than or equal to 2 at 90 days. In addition to outcome, cerebral edema was analyzed. The severity of brain edema was graded into three levels according to Thrombolysis in Stroke-Monitoring Study. Malignant cerebral edema (MCE) was defined as brain edema with midline shift.
Results
278 patients were included. 140 (50.4%) achieved favorable outcome, 35 (12.6%) developed MCE. In patients with favorable outcomes, the levels of SII, NLR and PLR were lower compared to those with unfavorable outcomes [422.33 (258.69-624.68) vs 1269.83 (750.82-2497.22), p < 0.001; 2.73 (1.68-4.40) vs 4.76 (2.59-7.72), p < 0.001; 92.98 (62.35-126.24) vs 115.64 (85.51-179.04), p < 0.001]. The area under the Receiver Operating Characteristic curve was 0.698 for SII (95% CI = 0.637-0.760, p < 0.001), 0.694 for NLR (95% CI = 0.632-0.756, p < 0.001), 0.643 for PLR (95% CI = 0.579-0.707, p < 0.001). The optimal cut-off values were 652.73 for SII (sensitivity 0.572, specificity 0.786), 3.57 for NLR (sensitivity 0.659, specificity 0.693), 127.01 for PLR (sensitivity 0.457, specificity 0.757).
Conclusions
An early increase in SII levels was related to 3 months of unfavorable outcomes in AIS patients after IVT. However, it is not associated with malignant edema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Chengdu Medical College, Chengdu, Sichuan, China.
- Department of Neurology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
- Department of Neurosurgery, Dujiangyan Medical Center, Chengdu, Sichuan, China.
- Biomedical Informatics and Digital Health, School of Medical Sciences, University of Sydney, Sydney, Australia.
- Department of Medical Administration, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
ORCID-Profile: Jianping Yu
Förderung
- CSRD VA
- the Medical Research and Youth Innovation Project of Sichuan Province
- the Educational Reform Project of Chengdu Medical College
- the Key Project of 2022 Graduate Innovation Fund
Zitieren
APA
Zhou, Y., Yang, Q., Zhou, Z., Yang, X., Zheng, D., He, Z., Liu, Y., Xu, T., Yin, Y., Wei, W., Si, C., Zhang, B., & Yu, J. (2025). Systemic immune-inflammation index is associated with clinical outcome of acute ischemic stroke patients after intravenous thrombolysis treatment. PLOS ONE, 20(3), e0319920. https://doi.org/10.1371/journal.pone.0319920
Vancouver
Zhou Y, Yang Q, Zhou Z, Yang X, Zheng D, He Z, et al. Systemic immune-inflammation index is associated with clinical outcome of acute ischemic stroke patients after intravenous thrombolysis treatment. PLOS ONE. 2025;20(3):e0319920. doi:10.1371/journal.pone.0319920
BibTeX
@article{Zhou2025,
author = {Zhou, Yuanfeng and Yang, Qian and Zhou, Zhangming and Yang, Xin and Zheng, Danni and He, Zhongchun and Liu, Yizhou and Xu, Tianzhu and Yin, Ying and Wei, Wenhui and Si, Chunli and Zhang, Bozhi and Yu, Jianping},
title = {Systemic immune-inflammation index is associated with clinical outcome of acute ischemic stroke patients after intravenous thrombolysis treatment},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {3},
pages = {e0319920},
doi = {10.1371/journal.pone.0319920}
}
EUVIMED